Wealth Enhancement Advisory Services, LLC Cognition Therapeutics Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,000 shares of CGTX stock, worth $3,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$3,100
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
14MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.86 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$683,6660.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$384,1410.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$312,3510.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$188,6000.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $7.04M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...